GLI1 and cancer: Given the established role of aberrant SHH signaling in tumorigenesis of several human cancers, understanding the fundamental mechanisms of SHH pathway regulation and the impact of alternative GLI1 splice variants will aid the development of novel therapeutics and achieve improved therapeutic outcomes for these patients.